Skip to main content
TipRanks
Go Ultimate75% OFF

Redcare Pharmacy (SAE) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

Redcare Pharmacy has a market cap or net worth of CHF 1.27B. The enterprise value is CHF 1.72B.

Market Cap
CHF 1.27B
Enterprise Value
CHF 1.72B

Share Statistics

Redcare Pharmacy has 20,578,390 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
20,578,390
Owned by Insiders
2.10%
Owned by Institutions
13.97%

Financial Efficiency

Redcare Pharmacy’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -2.11%.

Return on Equity (ROE)
-0.08
Return on Assets (ROA)
-0.03
Return on Invested Capital (ROIC)
-2.11%
Return on Capital Employed (ROCE)
-0.03
Revenue Per Employee
1.36M
Profits Per Employee
-17.43K
Employee Count
2,163
Asset Turnover
2.36
Inventory Turnover
10.97

Valuation Ratios

The current PE Ratio of Redcare Pharmacy is -38.25. Redcare Pharmacy’s PEG ratio is 15.98.

PE Ratio
-38.25
PS Ratio
0.39
PB Ratio
2.85
Price to FCF
-40.63
Price to Operating Cash Flow
30.37
PEG Ratio
15.98

Income Statement

In the last 12 months, Redcare Pharmacy had revenue of 2.94B and earned -37.70M in profits. Earnings per share was -1.87.

Revenue
2.94B
Gross Profit
593.70M
Operating Income
-23.80M
Pretax Income
-47.70M
Net Income
-37.70M
EBITDA
45.60M
Earnings Per Share (EPS)
-1.87

Cash Flow

In the last 12 months, operating cash flow was 42.96M and capital expenditures -75.06M, giving a free cash flow of -32.11M billion.

Operating Cash Flow
42.96M
Free Cash Flow
-32.11M
Free Cash Flow per Share
-1.59

Dividends & Yields

Redcare Pharmacy pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-2.46%
Earnings Yield
-2.61%

Stock Price Statistics

Beta
-0.14
52-Week Price Change
118.96%
50-Day Moving Average
64.28
200-Day Moving Average
54.09
Relative Strength Index (RSI)
43.99
Average Volume (3m)
81

Important Dates

Redcare Pharmacy upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 29, 2026
Next Earnings Date
Mar 03, 2027
Ex-Dividend Date
―

Financial Position

Redcare Pharmacy as a current ratio of 1.55, with Debt / Equity ratio of 90.51%

Current Ratio
1.55
Quick Ratio
1.01
Debt to Market Cap
0.27
Net Debt to EBITDA
7.09
Interest Coverage Ratio
-1.17

Taxes

In the past 12 months, Redcare Pharmacy has paid -8.30M in taxes.

Income Tax
-8.30M
Effective Tax Rate
0.17

Enterprise Valuation

Redcare Pharmacy EV to EBITDA ratio is 19.64, with an EV/FCF ratio of -48.88.

EV to Sales
0.47
EV to EBITDA
19.64
EV to Free Cash Flow
-48.88
EV to Operating Cash Flow
36.54

Balance Sheet

Redcare Pharmacy has CHF 132.40M in cash and marketable securities with CHF 354.50M in debt, giving a net cash position of -CHF 222.10M billion.

Cash & Marketable Securities
CHF 132.40M
Total Debt
CHF 354.50M
Net Cash
-CHF 222.10M
Net Cash Per Share
-CHF 10.79
Tangible Book Value Per Share
CHF 4.45

Margins

Gross margin is 20.26%, with operating margin of 0.11%, and net profit margin of -1.02%.

Gross Margin
20.26%
Operating Margin
0.11%
Pretax Margin
-0.93%
Net Profit Margin
-1.02%
EBITDA Margin
2.39%
EBIT Margin
0.16%

Analyst Forecast

The average price target for Redcare Pharmacy is CHF 87.38, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
CHF 87.38
Price Target Upside
33.91% Upside
Analyst Consensus
Strong Buy
Analyst Count
7
Revenue Growth Forecast
16.86%
EPS Growth Forecast
4.21%

Scores

Smart Score
8
AI Score
―